Business, energy, technology, markets and global industry news from Business News Today

American Society of Nephrology

PharmaDeviceNews American Society of Nephrology
Mezzion’s investigational drug udenafil has reduced kidney cyst burden in an ADPKD animal study, strengthening the scientific rationale for the company’s planned Phase 2b clinical programme. Representative image.
Pharma & Biotech

Keenova’s TERLIVAZ shows kidney response in transplant-ineligible patients as new CONFIRM analysis emerges

Keenova's TERLIVAZ analysis examines kidney recovery in transplant-ineligible HRS-AKI patients as respiratory safety and survival remain key concerns.

Read More
Vexev is advancing its VxWave robotic vascular ultrasound platform toward FDA 510(k) clearance and U.S. commercialization after raising $6 million to support regulatory work, manufacturing scale-up and deployment in dialysis care. Representative image.
Medical Devices & Diagnostics

Vexev says dialysis staff can operate its robotic ultrasound system. A $6m raise now puts the FDA test in focus

Australian medical robotics company Vexev has raised $6 million to support FDA regulatory work, manufacturing scale-up and U.S. commercialization of VxWave after a multicenter study showed that dialysis-clinic staff could perform semi-autonomous vascular scans with the investigational system.

Read More